NKTR
Nektar Therapeutics · Healthcare
Chief R, D Officer Jonathan Zalevsky sold $343K of Nektar Therapeutics
Sold$342,779
$4.65Price
73,716Shares
−18%Stake
What NKTR did after the filing
- The stock from Fri, Aug 19 close, $69.00
- −31.7%
- S&P 500, same days
- −12.8%
Measured over 30 trading days, to the Oct 3 close.
Traded Thu, Aug 18. Filed Fri, Aug 19, 2:27 PM ET, during the session. Returns use the Aug 19 close and the Oct 3 close. Not investment advice.